Press Releases

The global Contrast Media market is expected to grow at a CAGR of 4.2% during the forecast period. The increasing volume of CT and MRI examinations performed, a surge in number of the diagnostic centers and hospitals, and increasing incidences of chronic diseases and gastrointestinal tract in the United States and Canada will drive the market growth for Contrast Media in the healthcare industry. Furthermore, the market for contrast media agents is projected to expand due to an increase in medical tourism, which increases demand for radiopharmaceuticals worldwide. Moreover, the implementation of digital solutions to help contrast agent injection management is expected to drive market growth. Furthermore, minimally invasive therapies and image-guided procedures are becoming prominent among patients and healthcare professionals globally. Since it was first used for obstetrics and gynecology diagnostic imaging, ultrasonography has experienced significant development to treat kidney stones, cancer, and other clinical diseases. These activities will probably open up new revenue-boosting prospects for contrast media manufacturers. Nevertheless, marketing firms operating in the contrast media sector are introducing cutting-edge innovations in product design and technology.

GE Healthcare has pledged to boost the production of iodinated contrast media, which is frequently used in computed tomography and X-Ray Imaging, by 30 million yearly by 2025. To this end, the company entered into a multi-year partnership in October 2022, with Sociedad Quimica y Minera de Chile S.A. (SQM), a mining company in Chile, thereby increasing the supply of raw iodine.

Bowse 73 market data Tables and 45 Figures spread through 230 Pages and in-depth TOC on "Contrast Media Market by Media Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media, Barium-Based Contrast Media, and Others), by Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders), by Modality (X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Catheterization Laboratory, Ultrasound, and Others), by Route of Administration (Intravascular Route, Oral Route, Rectal Route, and Others), by Application (Radiology, Interventional Radiology, and Interventional Cardiology), and Region - Global Forecast to 2030

By Indication, the cancer segment will witness a significant market share during the forecast period.

Based on Indication, the Global Contrast Media Market is divided into Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, and Nephrological Disorders. The cancer segment is expected to grow significantly owing to rising incidences of cancer patients resulting in increased demand for diagnostics. The second most common cause of cancer-related death in developed nations is colorectal cancer. Many imaging techniques, such as optical colonoscopy and computed tomography colonography, are used to detect colorectal cancer (CTC).

Global Contrast Media Market Segmentation Analysis

Discover More About This Report, Download A Free Sample Copy of the Global Contrast Media Market

“North America is expected to witness largest market revenue during the forecast period in the Global Contrast Media Industry.”

North America is expected to generate the largest market revenue during the forecast period owing to increased healthcare expenditure, the presence of well-established healthcare facilities, increased market demand for diagnostic procedures, rising incidences of cancer and cardiac disorders, and availability of developed technology.

Some of the major players in the global Contrast Media industry include GE HealthCare, Bracco, Bayer AG, Guerbet, DAIICHI SANKYO COMPANY, LIMITED, Lantheus, TAEJOON PHARM, Magnus Health, Nano THERAPEUTICS PVT.LTD., and Trivitron Healthcare.

Scope of the Report

Global Contrast Media Market Coverage

Media Type Insight and Forecast 2018-2030

• Iodinated Contrast Media
• Gadolinium-Based Contrast Media
• Microbubble Contrast Media
• Barium-Based Contrast Media
• Others

Indication Insight and Forecast 2018-2030

• Cardiovascular Disorders
• Cancer
• Gastrointestinal Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Nephrological Disorders

Modality Insight and Forecast 2018-2030

• X-Ray
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Catheterization Laboratory
• Ultrasound
• Others

Route of Administration Insight and Forecast 2018-2030

• Intravascular Route
• Oral Route
• Rectal Route
• Others

Application Insight and Forecast 2018-2030

• Radiology
• Interventional Radiology
• Interventional Cardiology

Geographical Segmentation

Contrast Media Market by Region

North America

• By Media Type
• By Indication
• By Modality
• By Route of Administration
• By Application
• By Country – U.S., Canada, and Mexico

Europe

• By Media Type
• By Indication
• By Modality
• By Route of Administration
• By Application
• By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

• By Media Type
• By Indication
• By Modality
• By Route of Administration
• By Application
• By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

• By Media Type
• By Indication
• By Modality
• By Route of Administration
• By Application
• By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries